About the Speaker

Steven Finkbeiner, MD, PhD
Gladstone Institutes
University of California, San Francisco
2022 Leslie Gehry Prize for Innovation in Science Recipient

Dr. Steven Finkbeiner is interested in understanding mechanisms of neurodegenerative disease and developing therapeutic strategies and therapies. He has studied HD since 1998, inventing and applying innovative methods and tools, including robotic microscopy, stem cells and artificial intelligence. His landmark study in 2004 in Nature changed the way the field thought about the hallmark pathology in Huntington’s disease, the most cited paper in neuroscience for the decade. With philanthropists in the San Francisco Bay Area, he established the Taube-Koret Center, which works to translate the most promising discoveries from the labs into therapeutics, often in partnership with drug companies. His most promising HD therapeutic strategy stimulates a pathway in cells that helps clear the abnormal Huntingtin protein.

Thank you to our webinar sponsor!